An example of artificial intelligence on the GE Healthcare Vivid E95 system shown at ASE 2019 where the AI automatically pulls in an exam, identifies the left ventricle and myocardial boards and then calculates all the strain measurements in less than 10 seconds. While AI automation can greatly speed workflow, there are questions about the accuracy of AI for the next step in making diagnoses.  #ASE #ASE21 #ASE2021 #AI

Artificial intelligence (AI) is growing in all areas of medicine and was the topic of several advanced technology sessions at the American Society of Echocardiography (ASE) 2021 meeting. Speakers pointed out that more work is needed to increase the quality and amount of data use to train cardiac ultrasound AI algorithms. 

September 8, 2021 — Adding systematic fractional flow reserve (FFR) assessment to coronary angiography does not reduce costs or improve quality of life in patients undergoing diagnosis for chest pain, nor does it reduce major adverse cardiac events or revascularization rates. That was the finding of late-breaking RIPCORD2 study presented in a Hot Line session at the 2021 European Society of Cardiology (ESC) Congress.[1]

September 8, 2021 — Continuous heart rhythm monitoring – with anticoagulation if atrial fibrillation is detected – does not prevent strokes in those at risk.

September 7, 2021 — Carotid artery surgery and stenting have comparable long-term effects on fatal or disabling stroke in asymptomatic patients with severe carotid artery stenosis.

September 7, 2021 — Remote monitoring of implantable cardiac monitors (ICMs) is highly effective for early detection of serious arrhythmias in high-risk post-infarction patients with cardiac autonomic dysfunction and moderately reduced ejection fraction. That was the finding from the SMART-MI late breaking research presented in a Hot Line session at the 2021 European Society of Cardiology (ESC) Congress.[1]

COVID in cardiology was again a key driver of content pageviews on DAIC in August 2021. Also, a key new technology that cardiologists had a lot of interest in was the release of 3D/4D intra-cardiac echocardiography (ICE) to better guide EP and structural heart procedures without the need for transesophageal echo and its associated need for deep anesthesia. 

September 3, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of August 2021. This is based on the website’s 201,568 pageviews for the month.
Drones Could Deliver Defibrillators or AEDs to sudden Cardiac Arrest Victims Faster Than Ambulances. Getty Images

September 1, 2021 — The world’s first feasibility study has found that drones can be used to deliver life-saving defibrillators to people with suspected cardiac arrest in the community.

September 1, 2021 — The STOPDAPT-2 ACS trial does not support the use of one month of dual antiplatelet therapy (DAPT) in acute coronary syndrome (ACS) patients undergoing stent implantation. That was the finding of late-breaking research presented in a Hot Line session at European Society of Cardiology (ESC) Congress 2021.[1]

American Society of Nuclear Medicine 2021 Scientific Sessions

September 1, 2021 – The anticoagulant edoxaban (Savaysa) may be just as effective as warfarin for preventing heart attack or stroke in patients with atrial fibrillation (AF) who undergo transcatheter aortic valve replacement (TAVR), according to a large-scale international study led by Mount Sinai.  

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now